Biomarker-Enriched Efficacy of Cetuximab-Based Therapy: Squamous Subset Analysis from S0819, A Phase Iii Trial of Chemotherapy with or Without Cetuximab in Advanced Nsclc.Fred R. Hirsch,Mary Weber Redman,Roy S. Herbst,Edward S. Kim,Thomas John Semrad,Lyudmila Bazhenova,Gregory A. Masters,Kurt R. Oettel,Perry Guaglianone,Christopher M. Reynolds,Anand B. Karnad,Susanne M. Arnold,Marileila Varella-Garcia,James Moon,Philip C. Mack,Charles David Blanke,Karen Kelly,David R. GandaraJournal of clinical oncology（2016）引用 4|浏览30AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
